ES2196164T3 - Cristales de factor de crecimiento transformable beta. - Google Patents

Cristales de factor de crecimiento transformable beta.

Info

Publication number
ES2196164T3
ES2196164T3 ES96927031T ES96927031T ES2196164T3 ES 2196164 T3 ES2196164 T3 ES 2196164T3 ES 96927031 T ES96927031 T ES 96927031T ES 96927031 T ES96927031 T ES 96927031T ES 2196164 T3 ES2196164 T3 ES 2196164T3
Authority
ES
Spain
Prior art keywords
beta
transformable
growth factor
tgf
crystals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96927031T
Other languages
English (en)
Inventor
Peer Mittl
Markus Grutter
Tudor Arvinte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2196164T3 publication Critical patent/ES2196164T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

LA INVENCION SE REFIERE A TGF QUE NO MUESTRA ADSORCION O MENOS ADSORCION A LA PARED DE VIALES QUE EL TGF DE UNA PREPARACION FARMACEUTICA DE LIBERACION LENTA.
ES96927031T 1995-07-25 1996-07-17 Cristales de factor de crecimiento transformable beta. Expired - Lifetime ES2196164T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810484 1995-07-25

Publications (1)

Publication Number Publication Date
ES2196164T3 true ES2196164T3 (es) 2003-12-16

Family

ID=8221775

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96927031T Expired - Lifetime ES2196164T3 (es) 1995-07-25 1996-07-17 Cristales de factor de crecimiento transformable beta.

Country Status (12)

Country Link
US (1) US6294656B1 (es)
EP (1) EP0840748B1 (es)
JP (1) JP4246795B2 (es)
AT (1) ATE236929T1 (es)
AU (1) AU6700696A (es)
CA (1) CA2225963C (es)
DE (1) DE69627340T2 (es)
DK (1) DK0840748T3 (es)
ES (1) ES2196164T3 (es)
PT (1) PT840748E (es)
WO (1) WO1997005166A1 (es)
ZA (1) ZA966274B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6079213A (en) * 1997-12-12 2000-06-27 Magnetic Imaging Technologies Incorporated Methods of collecting, thawing, and extending the useful life of polarized gases and associated accumulators and heating jackets
US6128918A (en) * 1998-07-30 2000-10-10 Medi-Physics, Inc. Containers for hyperpolarized gases and associated methods
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
SG176314A1 (en) 2002-12-31 2011-12-29 Altus Pharmaceuticals Inc Human growth hormone crystals and methods for preparing them
US20050074453A1 (en) * 2003-10-02 2005-04-07 Ferree Bret A. Methods of preventing adhesions following laminectomies and other surgical procedures
ES2403357T3 (es) 2003-12-11 2013-05-17 Isto Technologies Inc. Sistema de cartílago particulado
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
EP2120859B1 (en) * 2006-12-21 2013-11-20 Stryker Corporation Sustained-release formulations comprising bmp-7 crystals
US20090012629A1 (en) 2007-04-12 2009-01-08 Isto Technologies, Inc. Compositions and methods for tissue repair
GB0724204D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for inhibition of scarring
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1126561B (de) 1960-07-05 1962-03-29 Hoechst Ag Verfahren zur Herstellung von mikrokristallinem Insulin
DE2256215C3 (de) 1972-11-16 1981-01-08 Hoechst Ag, 6000 Frankfurt Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin
EG12098A (en) 1974-04-13 1980-12-31 Hoechst Ag New pharmaceutical insulin preparations having antidiabetic activity and process for their manufacture
DE2933946A1 (de) 1979-08-22 1981-03-12 Hoechst Ag, 6000 Frankfurt Insulinkristallsuspension und verfahren zu ihrer herstellung.
DE3327709A1 (de) 1983-07-29 1985-02-07 Hoechst Ag, 6230 Frankfurt Insulin-derivat-kristallsuspensionen, verfahren zu deren herstellung und deren verwendung
DE3327928A1 (de) 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
DE3606163A1 (de) 1986-02-26 1987-08-27 Hoechst Ag Vorrichtung zur applikation von arzneimittelsuspensionen
ATE101620T1 (de) 1988-06-23 1994-03-15 Hoechst Ag Mini-proinsulin, seine herstellung und verwendung.
US5322933A (en) 1992-05-07 1994-06-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Crystal structure of TGF-β-2
EP0670733A1 (en) 1993-09-29 1995-09-13 Alcon Laboratories, Inc. Compositions containing growth factors and antiplastic agents

Also Published As

Publication number Publication date
ZA966274B (en) 1997-01-27
JP2000502243A (ja) 2000-02-29
AU6700696A (en) 1997-02-26
PT840748E (pt) 2003-08-29
EP0840748A1 (en) 1998-05-13
WO1997005166A1 (en) 1997-02-13
DK0840748T3 (da) 2003-07-28
CA2225963A1 (en) 1997-02-13
CA2225963C (en) 2008-02-05
JP4246795B2 (ja) 2009-04-02
DE69627340T2 (de) 2004-02-05
US6294656B1 (en) 2001-09-25
ATE236929T1 (de) 2003-04-15
EP0840748B1 (en) 2003-04-09
DE69627340D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
ES2196164T3 (es) Cristales de factor de crecimiento transformable beta.
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
IT8821535A0 (it) Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.
IT1182723B (it) Tavoletta di sostanza attiva farmaceutica che si disgrega rapidamente stabili al magazzinaggio
NO170260C (no) Fremstilling av oksygen med hoey renhet
KR960009650B1 (en) Sustained release pharmaceutical composition of diltiazem
IL88719A0 (en) Novel crystal form of ciclosporin,its production and pharmaceutical compositions containing it
DK680788A (da) Indolcarboxylsyreestere og -amider, deres fremstilling of laegemidler indeholdende forbindelserne
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
ATE534636T1 (de) Krystalline form ii von ritonavir enthaltende pharmazeutische zusammensetzung und ihre herstellung
HU896805D0 (en) Process for preparation of cephalosporin derivatives and for manufacturing of pharmaceutical compositions containing these compounds as active ingredient
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
ES2075454T3 (es) Forma cristalina pura de rifapentina.
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
NO168648C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive nitrogenholdige derivater av epipodofyllotoksin-glukosidderivater.
GB8916355D0 (en) Cyclodextrin clathrates of 5-cyano-prostacycline derivatives and their use as drugs
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
PT86925A (pt) Process for the preparation of imidazodiazepine derivatives and of pharmaceutical compositions containing the same
IL85651A (en) Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds
DK670388D0 (da) Antibiotikumholdigt farmaceutisk praeparat
PT86837A (pt) Process for the preparation of novel heterocyclyl-2-propin-1-amines useful as dopamine beta-hydroxylase and of pharmaceutical compositions containing the same
PT91588A (pt) A process for the preparation of imidazodiazepine derivatives and of pharmaceutical compositions containing the same